A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/365 (2006.01) A61K 31/505 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2251972
The instant invention provides methods for preventing or reducing the risk of developing atherosclerosis, as well as for halting or slowing the progression of atherosclerotic disease once it has become clinically evident, comprising the administration of a therapeutically effective amount of an HMG-CoA RI in combination with folic acid or a pharmaceutically acceptable salt or ester thereof to a person who is at risk of developing atherosclerosis or who already has atherosclerotic disease.
La présente invention présente des méthodes tant pour prévenir ou réduire le risque de contracter l'athérosclérose, que pour enrayer cette maladie ou ralentir sa progression une fois qu'elle est devenue cliniquement évidente; elles consistent à administrer une quantité thérapeutique d'un HMG-CoA RI en combinaison avec l'acide folique ou encore un de ses sels ou esters pharmacocompatibles, à une personne qui risque de contracter l'athérosclérose ou qui est déjà atteinte.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Combination therapy for reducing the risks associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for reducing the risks associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for reducing the risks associated with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1542364